Cetera Investment Advisers’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.1M | Buy |
157,722
+3,392
| +2% | +$281K | 0.02% | 685 |
|
|
2025
Q1 | $12.5M | Buy |
154,330
+5,604
| +4% | +$454K | 0.02% | 666 |
|
|
2024
Q4 | $13.4M | Sell |
148,726
-3,665
| -2% | -$330K | 0.03% | 586 |
|
|
2024
Q3 | $15.1M | Sell |
152,391
-8,014
| -5% | -$792K | 0.03% | 523 |
|
|
2024
Q2 | $14.9M | Sell |
160,405
-4,815
| -3% | -$446K | 0.03% | 498 |
|
|
2024
Q1 | $15.7M | Buy |
165,220
+126,053
| +322% | +$12M | 0.04% | 475 |
|
|
2023
Q4 | $3.5M | Sell |
39,167
-17,898
| -31% | -$1.6M | 0.03% | 570 |
|
|
2023
Q3 | $4.17M | Buy |
57,065
+10,116
| +22% | +$739K | 0.04% | 472 |
|
|
2023
Q2 | $3.91M | Sell |
46,949
-1,896
| -4% | -$158K | 0.03% | 497 |
|
|
2023
Q1 | $3.72M | Sell |
48,845
-3,215
| -6% | -$245K | 0.03% | 490 |
|
|
2022
Q4 | $4.32M | Buy |
52,060
+7,587
| +17% | +$630K | 0.04% | 430 |
|
|
2022
Q3 | $3.53M | Sell |
44,473
-503
| -1% | -$39.9K | 0.07% | 296 |
|
|
2022
Q2 | $3.34M | Sell |
44,976
-1,135
| -2% | -$84.3K | 0.05% | 356 |
|
|
2022
Q1 | $4.14M | Sell |
46,111
-1,747
| -4% | -$157K | 0.06% | 326 |
|
|
2021
Q4 | $5.36M | Buy |
47,858
+34,990
| +272% | +$3.92M | 0.08% | 269 |
|
|
2021
Q3 | $1.62M | Sell |
12,868
-556
| -4% | -$69.9K | 0.03% | 598 |
|
|
2021
Q2 | $1.82M | Buy |
13,424
+772
| +6% | +$105K | 0.03% | 545 |
|
|
2021
Q1 | $1.72M | Buy |
12,652
+2,082
| +20% | +$282K | 0.03% | 466 |
|
|
2020
Q4 | $1.49M | Buy |
10,570
+5,091
| +93% | +$717K | 0.03% | 529 |
|
|
2020
Q3 | $611K | Sell |
5,479
-3,127
| -36% | -$349K | 0.05% | 340 |
|
|
2020
Q2 | $963K | Buy |
8,606
+2,987
| +53% | +$334K | 0.09% | 243 |
|
|
2020
Q1 | $435K | Buy |
5,619
+331
| +6% | +$25.6K | 0.05% | 327 |
|
|
2019
Q4 | $507K | Buy |
5,288
+36
| +0.7% | +$3.45K | 0.05% | 340 |
|
|
2019
Q3 | $399K | Buy |
5,252
+1,048
| +25% | +$79.6K | 0.05% | 345 |
|
|
2019
Q2 | $371K | Buy |
+4,204
| New | +$371K | 0.05% | 343 |
|